Laser In Situ Fenestration Study
NCT: NCT06411990 · RECRUITING
Brief Summary
The goal of this clinical trial is to learn about a new device, named the LIFE device, to treat people with aneurysms (swellings) in the aorta (large, main blood vessel that delivers blood from the heart to the body). The main questions this trial aims to answer are: * If the LIFE device works to treat aortic aneurysms * What medical problems participants have when the LIFE device is used Participants will undergo treatment with the LIFE device and thereafter at 30 days, 6 months, 1 year, 2 years, 3 years, 4 years, and 5 years have their pulses checked, bloodwork to check kidney function (BUN and serum creatinine), and a CT scan of the aneurysm area.
Frequently Asked Questions
What is Laser In Situ Fenestration Study?
Laser In Situ Fenestration Study is a clinical trial registered under NCT06411990. Current status: RECRUITING.
What is the status of NCT06411990?
The current status of NCT06411990 (Laser In Situ Fenestration Study) is: RECRUITING.
When did Laser In Situ Fenestration Study start?
Laser In Situ Fenestration Study started on 2024-10-15.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.